These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 10240271)

  • 1. FTC: our model product selection law relies on the pharmacist's expertise.
    Holmes PD
    Pharm Times; 1979 Feb; 45(2):36-9. PubMed ID: 10240271
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug product selection and the law.
    Fink JL
    Contemp Pharm Pract; 1979; 2(3):128-31. PubMed ID: 10242846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two U.S. agencies offer generic drug law.
    Fisher MJ
    Natl Underwrit Life Health; 1979 Jan; 83(2):2, 7. PubMed ID: 10239881
    [No Abstract]   [Full Text] [Related]  

  • 4. Understanding drug product selection legislation.
    Berger BA
    Contemp Pharm Pract; 1981; 4(2):89-93. PubMed ID: 10250914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ohio Generic Product Selection Law: influence on pharmacy practice.
    Hunter RH
    Med Mark Media; 1979 Jul; 14(7):33-6. PubMed ID: 10243269
    [No Abstract]   [Full Text] [Related]  

  • 6. Economic issues in the antisubstitution controversy.
    Sharpe TR
    Am J Pharm Sci Support Public Health; 1977; 149(2):53-9. PubMed ID: 910879
    [No Abstract]   [Full Text] [Related]  

  • 7. Potential and actual drug product selection rates in Florida.
    Vuturo GJ; McCormick WC; Krischer JP
    Contemp Pharm Pract; 1980; 3(3):163-70. PubMed ID: 10247872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forces and direction of drug product selection legislation.
    Stewart JE
    Med Mark Media; 1979 Jun; 14(6):34-6, 38-9. PubMed ID: 10242281
    [No Abstract]   [Full Text] [Related]  

  • 9. Legal implications of the pharmacist's expanded clinical roles: a challenge to the clinical pharmacist's competencies.
    Moore RC; Mikeal RL; Brewer BF; Burton SF
    Contemp Pharm Pract; 1979; 2(3):132-5. PubMed ID: 10297530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of competition on prescription-drug-product substitution.
    Kralewski JE; Pitt L; Dowd B
    N Engl J Med; 1983 Jul; 309(4):213-6. PubMed ID: 6866035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guidelines for pharmacists performing product selection.
    Am Pharm; 1990 Jul; NS30(7):40-1. PubMed ID: 2363394
    [No Abstract]   [Full Text] [Related]  

  • 12. Measuring statutory effectiveness and compliance with Rhode Island's Drug Product Selection law.
    Campbell NA; DiLorenzo AW; Hachadorian C; Scott MD
    R I Med J (1976); 1986 Dec; 69(12):585-8. PubMed ID: 3468594
    [No Abstract]   [Full Text] [Related]  

  • 13. Attitudes of pharmacists and physicians toward Florida's drug product selection law.
    Vuturo GJ; McCormick WC; Krischer JP
    Contemp Pharm Pract; 1980; 3(3):156-62. PubMed ID: 10247871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug product selection legislation: a comparative analysis.
    Wetherbee H; Sharpe TR
    Am J Pharm Sci Support Public Health; 1978; 150(6):171-6. PubMed ID: 576098
    [No Abstract]   [Full Text] [Related]  

  • 15. Substitution: expectations and realization.
    Gorrell JM
    Med Mark Media; 1981 May; 16(5):52, 54-7. PubMed ID: 10251529
    [No Abstract]   [Full Text] [Related]  

  • 16. How many patients still get the drug you prescribe?
    Rosenberg CL
    Med Econ; 1979 Sep; 56(18):35-6, 40, 44 passim. PubMed ID: 10243615
    [No Abstract]   [Full Text] [Related]  

  • 17. Schering report looks at pharmacist's role in improving patient compliance.
    Am J Hosp Pharm; 1992 Jul; 49(7):1614-6. PubMed ID: 1621712
    [No Abstract]   [Full Text] [Related]  

  • 18. A political economy perspective: why pharmacists may be reluctant to dispense generic medications.
    Pelton LE; Strutton D; Smith MC
    J Hosp Mark; 1994; 9(1):137. PubMed ID: 10142135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generic drugs provide no big savings so far in nation's health bill.
    Lublin JS; Jaroslovsky R
    Wall St J Midwest Ed; 1978 Dec; 59(38):1, 19. PubMed ID: 10239001
    [No Abstract]   [Full Text] [Related]  

  • 20. Letter: Antisubstitution vs. cooperative substitution.
    Jones ME; Helling DK; Widmer RB
    Am Fam Physician; 1976 Jul; 14(1):27. PubMed ID: 937160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.